Article
IRW prevents diet-induced non-alcoholic fatty liver disease by preserving mitochondrial content and enhancing hepatic fatty acid oxidation capacity
2023-08-09
Abstract excerpt
Non-alcoholic fatty liver disease (NAFLD) the hepatic manifestation of the metabolic syndrome, remains without approved pharmacological treatment, with lifestyle modifications being the first line of therapy. Alternative approaches, including food-derived bioactive peptides can aid in the management of metabolic conditions including hypertension, obesity and insulin resistance. IRW is a tripeptide produced from th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8bb6a7c4-57fb-521e-9606-7b6ebbe7ee02
- DOI
- 10.21203/rs.3.rs-3228961/v1
